PNLIPRP1
gene geneOn this page
Also known as PLRP1
Summary
PNLIPRP1 (pancreatic lipase related protein 1, HGNC:9156) is a protein-coding gene on chromosome 10q25.3, encoding Inactive pancreatic lipase-related protein 1 (P54315). May function as inhibitor of dietary triglyceride digestion.
Predicted to enable calcium ion binding activity; lipoprotein lipase activity; and phospholipase A1 activity. Predicted to be involved in several processes, including cholesterol homeostasis; high-density lipoprotein particle remodeling; and triglyceride catabolic process. Predicted to be located in extracellular region. Biomarker of prostate cancer.
Source: NCBI Gene 5407 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_006229
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9156 |
| Approved symbol | PNLIPRP1 |
| Name | pancreatic lipase related protein 1 |
| Location | 10q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PLRP1 |
| Ensembl gene | ENSG00000187021 |
| Ensembl biotype | protein_coding |
| OMIM | 604422 |
| Entrez | 5407 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 9 retained_intron, 7 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000358834, ENST00000470678, ENST00000471549, ENST00000480870, ENST00000482159, ENST00000482833, ENST00000484402, ENST00000497792, ENST00000510125, ENST00000525157, ENST00000525820, ENST00000526223, ENST00000527980, ENST00000528052, ENST00000529584, ENST00000530319, ENST00000530626, ENST00000531825, ENST00000531984, ENST00000534513, ENST00000534537
RefSeq mRNA: 2 — MANE Select: NM_006229
NM_001303135, NM_006229
CCDS: CCDS7595
Canonical transcript exons
ENST00000358834 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001097300 | 116594730 | 116594864 |
| ENSE00001832518 | 116590959 | 116590995 |
| ENSE00003474330 | 116591771 | 116591925 |
| ENSE00003486482 | 116601072 | 116601201 |
| ENSE00003497945 | 116597828 | 116597947 |
| ENSE00003514180 | 116605386 | 116605553 |
| ENSE00003519418 | 116609053 | 116609175 |
| ENSE00003603124 | 116600047 | 116600165 |
| ENSE00003611781 | 116592416 | 116592541 |
| ENSE00003643156 | 116598047 | 116598166 |
| ENSE00003662767 | 116604030 | 116604138 |
| ENSE00003758567 | 116591130 | 116591178 |
| ENSE00003787069 | 116596214 | 116596322 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 99.92.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.8555 / max 2032.7210, expressed in 6 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107238 | 1.3798 | 5 |
| 107239 | 0.3190 | 5 |
| 107237 | 0.1567 | 4 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.92 | gold quality |
| pancreas | UBERON:0001264 | 98.07 | gold quality |
| islet of Langerhans | UBERON:0000006 | 96.57 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.60 | silver quality |
| buccal mucosa cell | CL:0002336 | 73.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.58 | gold quality |
| frontal pole | UBERON:0002795 | 71.07 | gold quality |
| paraflocculus | UBERON:0005351 | 70.98 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 70.56 | gold quality |
| endometrium epithelium | UBERON:0004811 | 69.31 | gold quality |
| right coronary artery | UBERON:0001625 | 68.99 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 64.69 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 64.31 | gold quality |
| type B pancreatic cell | CL:0000169 | 64.28 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 63.74 | gold quality |
| ectocervix | UBERON:0012249 | 63.42 | gold quality |
| rectum | UBERON:0001052 | 63.35 | gold quality |
| triceps brachii | UBERON:0001509 | 63.23 | gold quality |
| oocyte | CL:0000023 | 62.71 | gold quality |
| right lobe of liver | UBERON:0001114 | 62.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 61.95 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 61.85 | gold quality |
| endocervix | UBERON:0000458 | 61.84 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 61.68 | gold quality |
| left uterine tube | UBERON:0001303 | 61.36 | gold quality |
| transverse colon | UBERON:0001157 | 60.98 | gold quality |
| fundus of stomach | UBERON:0001160 | 60.63 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 60.34 | gold quality |
| diaphragm | UBERON:0001103 | 60.26 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-5061 | yes | 4369.04 |
| E-GEOD-81547 | yes | 31.32 |
| E-HCAD-31 | no | 3.16 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Low PNLIPRP1 expression is associated with pancreatic cancer. (PMID:23918603)
- Pancreatic lipase and its related proteins: where are we now? (PMID:38081381)
- PNLIPRP1 Hypermethylation in Exocrine Pancreas Links Type 2 Diabetes and Cholesterol Metabolism. (PMID:39137110)
Cross-species orthologs
28 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pnliprp1 | ENSMUSG00000042179 |
| rattus_norvegicus | Pnliprp1 | ENSRNOG00000017908 |
| drosophila_melanogaster | Yp1 | FBGN0004045 |
| drosophila_melanogaster | Yp3 | FBGN0004047 |
| drosophila_melanogaster | Yp2 | FBGN0005391 |
| drosophila_melanogaster | CG5162 | FBGN0030828 |
| drosophila_melanogaster | CG6847 | FBGN0030884 |
| drosophila_melanogaster | CG7367 | FBGN0031976 |
| drosophila_melanogaster | CG13282 | FBGN0032612 |
| drosophila_melanogaster | CG6675 | FBGN0032973 |
| drosophila_melanogaster | CG6472 | FBGN0034166 |
| drosophila_melanogaster | CG10163 | FBGN0035697 |
| drosophila_melanogaster | CG10116 | FBGN0036367 |
| drosophila_melanogaster | CG5665 | FBGN0036977 |
| drosophila_melanogaster | sxe2 | FBGN0038398 |
| drosophila_melanogaster | CG4582 | FBGN0039344 |
| drosophila_melanogaster | CG6296 | FBGN0039470 |
| drosophila_melanogaster | CG6295 | FBGN0039471 |
| drosophila_melanogaster | CG17192 | FBGN0039472 |
| drosophila_melanogaster | CG17191 | FBGN0039473 |
| drosophila_melanogaster | CG6283 | FBGN0039474 |
| drosophila_melanogaster | CG6277 | FBGN0039475 |
| drosophila_melanogaster | CG6271 | FBGN0039476 |
| drosophila_melanogaster | CG34447 | FBGN0085476 |
| drosophila_melanogaster | CG34448 | FBGN0085477 |
| drosophila_melanogaster | CG14034 | FBGN0250847 |
| drosophila_melanogaster | CG4267 | FBGN0264979 |
| drosophila_melanogaster | CG18258 | FBGN0265267 |
Paralogs (9): LIPG (ENSG00000101670), PLA1A (ENSG00000144837), LIPH (ENSG00000163898), LIPC (ENSG00000166035), LPL (ENSG00000175445), PNLIP (ENSG00000175535), LIPI (ENSG00000188992), PNLIPRP3 (ENSG00000203837), PNLIPRP2 (ENSG00000266200)
Protein
Protein identifiers
Inactive pancreatic lipase-related protein 1 — P54315 (reviewed: P54315)
All UniProt accessions (8): E7EX42, E9PJC9, E9PMA6, E9PMX6, E9PR20, E9PRT6, P54315, H0YDY1
UniProt curated annotations — full annotation on UniProt →
Function. May function as inhibitor of dietary triglyceride digestion. Lacks detectable lipase activity towards triglycerides, diglycerides, phosphatidylcholine, galactolipids or cholesterol esters (in vitro).
Subcellular location. Secreted.
Tissue specificity. Pancreas.
Similarity. Belongs to the AB hydrolase superfamily. Lipase family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P54315-1 | 1 | yes |
| P54315-2 | 2 | |
| P54315-3 | 3 |
RefSeq proteins (2): NP_001290064, NP_006220* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000734 | TAG_lipase | Family |
| IPR001024 | PLAT/LH2_dom | Domain |
| IPR002331 | Lipase_panc | Family |
| IPR013818 | Lipase | Domain |
| IPR016272 | Lipase_LIPH | Family |
| IPR029058 | AB_hydrolase_fold | Homologous_superfamily |
| IPR033906 | Lipase_N | Domain |
| IPR036392 | PLAT/LH2_dom_sf | Homologous_superfamily |
Pfam: PF00151, PF01477
Enzyme classification (BRENDA):
- EC 3.1.1.26 — galactolipase (BRENDA: 63 organisms, 125 substrates, 44 inhibitors, 15 Km, 2 kcat entries)
Substrate kinetics (BRENDA)
6 substrates with measured Km, best-characterized 6. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| MONOGALACTOSYLDIACYLGLYCEROL | 0.119–0.65 | 6 |
| PHOSPHATIDYLCHOLINE | 0.53–1.7 | 3 |
| 1,2-DIACYL-3-O-ALPHA-D-GALACTOSYL-(1->6)-BETA-D- | 0.54–1.05 | 2 |
| DIGALACTOSYLDIACYLGLYCEROL | 0.31 | 1 |
| DIGALACTOSYLDILINOLENIN | 7.8 | 1 |
| MONOGALACTOSYLDILINOLENIN | 1.5 | 1 |
UniProt features (66 total): strand 23, helix 13, disulfide bond 6, sequence variant 5, turn 5, splice variant 4, binding site 4, active site 3, signal peptide 1, chain 1, domain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2PPL | X-RAY DIFFRACTION | 2.2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P54315-F1 | 94.54 | 0.88 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 171 (nucleophile); 194 (charge relay system); 281 (charge relay system)
Ligand- & substrate-binding residues (4): 205; 208; 210; 213
Disulfide bonds (6): 21–27, 109–120, 255–279, 303–314, 317–322, 451–467
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-192456 | Digestion of dietary lipid |
| R-HSA-8935690 | Digestion |
| R-HSA-8963743 | Digestion and absorption |
MSigDB gene sets: 120 (showing top):
YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_STEROL_HOMEOSTASIS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, LEE_LIVER_CANCER_CIPROFIBRATE_DN, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_LIPID_HOMEOSTASIS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, GATA6_01, GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS, GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS, GATA1_04, GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS
GO Biological Process (6): fatty acid biosynthetic process (GO:0006633), triglyceride catabolic process (GO:0019433), high-density lipoprotein particle remodeling (GO:0034375), cholesterol homeostasis (GO:0042632), lipid metabolic process (GO:0006629), lipid catabolic process (GO:0016042)
GO Molecular Function (8): lipoprotein lipase activity (GO:0004465), triacylglycerol lipase activity (GO:0004806), calcium ion binding (GO:0005509), glycerophospholipid phospholipase A1 activity (GO:0008970), protein binding (GO:0005515), lipase activity (GO:0016298), metal ion binding (GO:0046872), carboxylic ester hydrolase activity (GO:0052689)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Digestion | 1 |
| Digestion and absorption | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| hydrolase activity, acting on ester bonds | 2 |
| fatty acid metabolic process | 1 |
| lipid biosynthetic process | 1 |
| monocarboxylic acid biosynthetic process | 1 |
| triglyceride metabolic process | 1 |
| acylglycerol catabolic process | 1 |
| plasma lipoprotein particle remodeling | 1 |
| sterol homeostasis | 1 |
| primary metabolic process | 1 |
| lipid metabolic process | 1 |
| catabolic process | 1 |
| triacylglycerol lipase activity | 1 |
| lipase activity | 1 |
| carboxylic ester hydrolase activity | 1 |
| metal ion binding | 1 |
| A1-type glycerophospholipase activity | 1 |
| binding | 1 |
| cation binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
622 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PNLIPRP1 | CLPS | P04118 | 959 |
| PNLIPRP1 | LIPF | P07098 | 920 |
| PNLIPRP1 | CEL | P19835 | 696 |
| PNLIPRP1 | PLA2G1B | P04054 | 606 |
| PNLIPRP1 | SYCN | Q0VAF6 | 582 |
| PNLIPRP1 | CPA1 | P15085 | 544 |
| PNLIPRP1 | CELA2A | P08217 | 541 |
| PNLIPRP1 | CELA3B | P08861 | 507 |
| PNLIPRP1 | CPA2 | P48052 | 470 |
| PNLIPRP1 | MBOAT1 | Q6ZNC8 | 460 |
| PNLIPRP1 | CPB1 | P15086 | 430 |
| PNLIPRP1 | CELA3A | P09093 | 420 |
| PNLIPRP1 | HSPA12A | O43301 | 418 |
| PNLIPRP1 | SHTN1 | A0MZ66 | 411 |
| PNLIPRP1 | PNLIP | P16233 | 382 |
IntAct
127 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PNLIPRP1 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | CERS4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | HSD17B13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | GJA8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | TSPAN8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | SLC18A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | STX1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | GDAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| FFAR2 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | SLC10A6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| NEMP1 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | NDUFAF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP2 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNLIPRP1 | FAM209A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC7A1 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX12 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (60): PNLIPRP1 (Two-hybrid), ITGA8 (Affinity Capture-MS), TMEM2 (Affinity Capture-MS), NPTX1 (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), GPR98 (Affinity Capture-MS), CACNA2D2 (Affinity Capture-MS), UBR1 (Affinity Capture-MS), UBR2 (Affinity Capture-MS), PNLIPRP1 (Two-hybrid), PNLIPRP1 (Two-hybrid), PNLIPRP1 (Two-hybrid), PNLIPRP1 (Two-hybrid), PNLIPRP1 (Two-hybrid), PNLIPRP1 (Two-hybrid)
ESM2 similar proteins: A0A0M3KKW3, A2VBC4, A5PK46, A8PUY1, B2D0J5, C0HLL3, D7EZN2, O88354, P00591, P06857, P0CH47, P0CH86, P0CH87, P0DMB4, P0DMB5, P0DPT0, P0DSI2, P16233, P17892, P27657, P29183, P35501, P35502, P49369, P50903, P51528, P53357, P54315, P54316, P54317, P54318, P81139, P86100, P9WEM6, Q02157, Q04456, Q06478, Q17RR3, Q3ZU95, Q5BKQ4
Diamond homologs: A0A0M3KKW3, A2VBC4, C0HLL3, O46559, P06857, P07867, P0CH47, P0CH86, P0CH87, P0DMB4, P0DMB5, P0DMB7, P0DMB8, P0DPT0, P0DSI2, P11150, P11602, P27656, P29183, P49369, P51528, P53357, P54315, P54316, P81139, Q02157, Q06478, Q3SZ79, Q3ZU95, Q5BKQ4, Q5XGE9, Q68KK0, Q6NYZ4, Q6Q249, Q6Q250, Q6Q251, Q6Q252, Q6XZB0, Q7M3V3, Q7M3V4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1693 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:116591926:G:GG | donor_gain | 1.0000 |
| 10:116594725:A:AG | acceptor_gain | 1.0000 |
| 10:116594729:GAA:G | acceptor_gain | 1.0000 |
| 10:116594865:G:GG | donor_gain | 1.0000 |
| 10:116600162:GTCT:G | donor_gain | 1.0000 |
| 10:116601182:A:T | donor_gain | 1.0000 |
| 10:116601197:CGCTC:C | donor_gain | 1.0000 |
| 10:116601198:GCTC:G | donor_gain | 1.0000 |
| 10:116601198:GCTCG:G | donor_gain | 1.0000 |
| 10:116601199:CTC:C | donor_gain | 1.0000 |
| 10:116601200:TC:T | donor_gain | 1.0000 |
| 10:116601200:TCGTA:T | donor_loss | 1.0000 |
| 10:116601202:G:GA | donor_loss | 1.0000 |
| 10:116601202:G:GG | donor_gain | 1.0000 |
| 10:116601203:TAA:T | donor_loss | 1.0000 |
| 10:116601204:AAGTT:A | donor_loss | 1.0000 |
| 10:116604134:TTCAG:T | donor_loss | 1.0000 |
| 10:116604137:AG:A | donor_loss | 1.0000 |
| 10:116604138:GGT:G | donor_loss | 1.0000 |
| 10:116604139:G:C | donor_loss | 1.0000 |
| 10:116604140:T:A | donor_loss | 1.0000 |
| 10:116605552:GT:G | donor_gain | 1.0000 |
| 10:116605554:G:GG | donor_gain | 1.0000 |
| 10:116591175:AAAGG:A | donor_loss | 0.9900 |
| 10:116591176:AAGGT:A | donor_loss | 0.9900 |
| 10:116591179:G:T | donor_loss | 0.9900 |
| 10:116591180:T:A | donor_loss | 0.9900 |
| 10:116591925:AG:A | donor_loss | 0.9900 |
| 10:116591926:G:GA | donor_loss | 0.9900 |
| 10:116591927:TGAGA:T | donor_loss | 0.9900 |
AlphaMissense
3095 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:116600082:A:C | S284R | 0.994 |
| 10:116600084:C:A | S284R | 0.994 |
| 10:116600084:C:G | S284R | 0.994 |
| 10:116600103:A:C | S291R | 0.992 |
| 10:116600105:C:A | S291R | 0.992 |
| 10:116600105:C:G | S291R | 0.992 |
| 10:116594772:T:A | W125R | 0.991 |
| 10:116594772:T:C | W125R | 0.991 |
| 10:116597851:T:C | F200L | 0.991 |
| 10:116597853:C:A | F200L | 0.991 |
| 10:116597853:C:G | F200L | 0.991 |
| 10:116596259:A:C | S171R | 0.990 |
| 10:116596261:C:A | S171R | 0.990 |
| 10:116596261:C:G | S171R | 0.990 |
| 10:116594774:G:C | W125C | 0.989 |
| 10:116594774:G:T | W125C | 0.989 |
| 10:116597903:T:A | V217D | 0.987 |
| 10:116597914:C:G | H221D | 0.987 |
| 10:116596322:G:T | G192W | 0.986 |
| 10:116597876:G:C | R208P | 0.986 |
| 10:116597879:T:A | L209H | 0.986 |
| 10:116598115:T:A | C255S | 0.986 |
| 10:116598116:G:C | C255S | 0.986 |
| 10:116594816:C:A | N139K | 0.985 |
| 10:116594816:C:G | N139K | 0.985 |
| 10:116596260:G:T | S171I | 0.985 |
| 10:116600073:C:G | H281D | 0.985 |
| 10:116605471:T:A | W420R | 0.985 |
| 10:116605471:T:C | W420R | 0.985 |
| 10:116600075:C:A | H281Q | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000301278 (10:116596230 C>A,T), RS1000745637 (10:116603878 G>A), RS1001500715 (10:116592135 C>G), RS1001598230 (10:116591357 G>A,T), RS1001649350 (10:116597396 A>G), RS1001982878 (10:116599004 C>G), RS1001985833 (10:116592175 T>C), RS1002035441 (10:116598817 C>A), RS1003192907 (10:116606087 G>A), RS1003267175 (10:116604565 T>C), RS1003601213 (10:116593911 C>G,T), RS1003656013 (10:116605787 C>T), RS1004058493 (10:116593717 A>G), RS1004262396 (10:116599070 C>T), RS1004314721 (10:116605240 G>A)
Disease associations
OMIM: gene MIM:604422 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002324_9 | Anger | 4.000000e-06 |
| GCST003771_4 | Loneliness | 1.000000e-06 |
| GCST003772_15 | Loneliness (linear analysis) | 8.000000e-07 |
| GCST003773_9 | Loneliness (multivariate analysis) | 4.000000e-06 |
| GCST005951_66 | Body mass index | 4.000000e-08 |
| GCST006585_2227 | Blood protein levels | 5.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003015 | aggressive behavior |
| EFO:0007865 | loneliness measurement |
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| Valproic Acid | affects methylation, increases methylation | 2 |
| tebuconazole | decreases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Tretinoin | affects expression | 1 |
| Vitamin E | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.